Allen Institute launches multi-hundred-million-dollar effort to turn brain atlas data into neurodegenerative drug candidates
read at Endpoints ↗Positive
The Allen Institute, a Seattle nonprofit known for basic brain research, announced a major new effort to move its brain‑atlas knowledge toward drug development.
The program will invest several hundred million dollars over the coming years to target neurodegenerative diseases such as Alzheimer's, using the institute's detailed maps of human brain cells.
This initiative marks a shift from pure research to translational medicine, aiming to partner with pharmaceutical companies and speed the discovery of new therapies.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Updated: Allen Institute launches $400M effort to turn brain atlas lessons into medicines”
read at Endpoints ↗110 words · retrieved Jun 2
comments(0)
5-min edit window · permanent after that